Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

2 May 2013 13:45

RNS Number : 8899D
Ark Therapeutics Group PLC
02 May 2013
 



 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ARK THERAPEUTICS GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 X

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

3. Full name of person(s) subject to the notification obligation:

 

 Smith and Williamson Holdings Limited

4. Full name of shareholder(s) (if different from 3.):

 

Detailed as per section 9

5. Date of the transaction and date on which the threshold is crossed or reached:

 

22/04/2013

6. Date on which issuer notified:

 

23/04/2013

7. Threshold(s) that is/are crossed or reached:

 

11%

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary

GB0034251727

23,477,100

23,477,100

21,477,100

10.26%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

 

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 N/A

 N/A

 N/A

 N/A

 N/A

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

21,477,100

10.26%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Smith and Williamson Nominees Limited, a subsidiary of Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 5,056,157 shares

 

Royal Bank of Scotland as custodian for Smith & Williamson Fund Administration Ltd, a subsidiary of Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 2,000,000 shares

 

BNP Paribas as custodian for Smith and Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 675,000 shares

 

BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 14,000,000 shares

 

Proxy Voting:

 

10. Name of the proxy holder:

 

 N/A

11. Number of voting rights proxy holder will cease to hold:

 

 N/A

12. Date on which proxy holder will cease to hold voting rights:

 

 N/A

13. Additional information:

 

14. Contact name:

 

Not advised

15. Contact telephone number:

 

Not advised

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUSUROUAVRAR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS